miglustat   Click here for help

GtoPdb Ligand ID: 4841

Synonyms: N-butyl-1-deoxynojirimycin | NB-DNJ | Zavesca®
Approved drug PDB Ligand
miglustat is an approved drug (EMA (2002), FDA (2003))
Compound class: Synthetic organic
Comment: Marketed formulations may contain miglustat hydrochloride (PubChem CID 71299591).
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 5
Hydrogen bond donors 4
Rotatable bonds 4
Topological polar surface area 84.16
Molecular weight 219.15
XLogP -0.2
No. Lipinski's rules broken 0
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES CCCCN1CC(O)C(C(C1CO)O)O
Isomeric SMILES CCCCN1C[C@H](O)[C@H]([C@@H]([C@H]1CO)O)O
InChI InChI=1S/C10H21NO4/c1-2-3-4-11-5-8(13)10(15)9(14)7(11)6-12/h7-10,12-15H,2-6H2,1H3/t7-,8+,9-,10-/m1/s1
InChI Key UQRORFVVSGFNRO-UTINFBMNSA-N
Transporters Moving this Compound Across a Lipid Membrane
Transporter EC number Reaction Reference
Low affinity sodium-glucose cotransporter 2
Selectivity at enzymes
Key to terms and symbols Click column headers to sort
Target Sp. Type Action Value Parameter Concentration range (M) Reference
UDP-glucose ceramide glucosyltransferase Primary target of this compound Hs Inhibitor Inhibition 5.1 pKi - 1
pKi 5.1 (Ki 7.4x10-6 M) [1]
Ligand mentioned in the following text fields